Effect of Tirzepatide versus insulin degludec on liver fat content and abdominal adipose tissue in people with type 2 diabetes (SURPASS-3 MRI): a substudy of the randomised, open-label, parallel-group, phase 3 SURPASS-3 trial
GLP-1 analogues have a unique property whereby it reduces neuroinflammation, reduces tau formation, reduces insulin resistance, reduces amyloid formation, and improves connection between the brain cells. Paul Edison, MD, PhD Edison and his team believe liraglutides brain protection may stem from causing a slower loss of brain volume
RGB Wash Angle: 148
Y.HammelG.GomezG
The format is usually "EXP" followed by the month and year (e.g., "EXP 06/2024")
In diabetic kidney disease patients, a reduction in insulin levels, albuminuria, and the progression of renal failure were observed as a GLP-1R effect [56, 57]